- |||||||||| Ravicti (glycerol phenylbutyrate) / Immedica, Amgen
New P2 trial: Use of Ravicti (clinicaltrials.gov) - Jun 18, 2013 P2, N=6, Recruiting,
- |||||||||| Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial termination: MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013 P1, N=23, Terminated, N=99 --> 147 Active, not recruiting --> Terminated; Replaced by another study
- |||||||||| Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment change: MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013 P1, N=23, Terminated, Active, not recruiting --> Terminated; Replaced by another study N=45 --> 23
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment closed, IO biomarker: acns0333: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System (clinicaltrials.gov) - Jun 9, 2013 P3, N=70, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
|